Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Endosc Int Open ; 11(6): E618-E622, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37854888

ABSTRACT

Background and study aims Transgastric endoscopic ultrasound (EUS)-guided drainage and, if needed, necrosectomy is the preferred treatment in patients with pancreatic walled-off necrosis. EUS-guided transcolonic or transrectal drainage and necrosectomy may serve as a minimally invasive alternative in cases in which transgastric or percutaneous drainage is either impossible or fails to secure sufficient drainage. In this paper, we retrospectively evaluated the feasibility, safety, and efficacy of the treatment. We included nine patients and found a technical success rate of 100%, clinical success in 89%, and one adverse event (11%). Transrectal/transcolonic endoscopic necrosectomy was needed in seven patients (78%).

2.
Scand J Gastroenterol ; 47(4): 467-74, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22401315

ABSTRACT

OBJECTIVES: Carvedilol is a non-selective ß-blocker with intrinsic anti-α(1)-adrenergic activity, potentially more effective than propranolol in reducing hepatic venous pressure gradient (HVPG). We compared the long-term effect of carvedilol and propranolol on HVPG and assessed whether the acute response to oral propranolol predicted the long-term HVPG response on either drug. MATERIAL AND METHODS: HVPG was measured in 38 patients with cirrhosis and HVPG ≥ 12 mm Hg at baseline and then again 90 min after an oral dose of 80 mg propranolol. Patients were double-blinded randomized to either carvedilol (21 patients) or propranolol (17 patients) and after 90 days of treatment HVPG measurements were repeated. RESULTS: HVPG decreased by 19.3 ± 16.1% (p < 0.01) and by 12.5 ± 16.7% (p < 0.01) in the carvedilol and propranolol groups, respectively, with no significant difference between treatment regimens (p = 0.21). Although insignificant, an acute decrease in HVPG of ≥12% was the best cut-off value to predict long-term HVPG response to propranolol when using ROC curve analysis. CONCLUSIONS: This randomized study showed that carvedilol is at least as effective as propranolol on HVPG after long-term administration. Furthermore, a predictive value of an acute propranolol test on HVPG could not be confirmed.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Carbazoles/therapeutic use , Hypertension, Portal/drug therapy , Liver Cirrhosis/drug therapy , Propanolamines/therapeutic use , Propranolol/therapeutic use , Administration, Oral , Adrenergic beta-Antagonists/administration & dosage , Carbazoles/administration & dosage , Carvedilol , Double-Blind Method , Female , Hepatic Veins/physiopathology , Humans , Hypertension, Portal/physiopathology , Liver Cirrhosis/physiopathology , Male , Middle Aged , Portal Pressure/drug effects , Predictive Value of Tests , Propanolamines/administration & dosage , Propranolol/administration & dosage , Treatment Outcome , Venous Pressure/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...